NEOGENOMICS INC

NEO Healthcare
$8.74
Market Cap $1.13B
P/E Ratio
Forward P/E 27.37
Dividend Yield
Beta 1.64
52W Range $4.72 - $13.74
# Hedge Funds 0
Sector Healthcare
Industry Diagnostics & Research

Hedge Fund Ownership

0 funds holding this stock
Investor 0 % of Portfolio i Weight of this stock in the investor's portfolio Value i Total dollar value of the position Shares i Number of shares held Activity i Portfolio change type: New, Increased, Decreased, or Sold

Insider Trading

5 transactions in the last 6 months
Insider i Name of the company insider who made the trade 5 Type i Purchase (buy) or Sale (sell) Shares i Number of shares traded Price i Price per share at time of transaction Value i Total dollar value of the transaction Trade Date i Date the transaction was executed Filing Date i Date the SEC filing was submitted
Stone WarrenPres & Chief Operating OfficerSale22,128$12.50$276.68K20 Jan 202621 Jan 2026
Olivo Alicia CEVP, GC & Business DevelopmentSale20,916$12.00$250.99K25 Nov 202528 Nov 2025
Alicia C OlivoEVP, GC & Business DevelopmentSale20,916$12.00$250.99K25 Nov 202528 Nov 2025
Olivo Alicia CEVP, GC & Business DevelopmentSale4,918$10.00$49.18K16 Oct 202520 Oct 2025
Alicia C OlivoEVP, GC & Business DevelopmentSale4,918$10.00$49.18K16 Oct 202520 Oct 2025

Frequently Asked Questions

What is NEO stock price today?

NEOGENOMICS INC (NEO) is currently trading at $8.74. The stock has a 52-week range of $4.72 to $13.74 and a market capitalization of $1.13B.

Is NEO a good stock to buy in 2026?

NEOGENOMICS INC has a P/E ratio of N/A (forward P/E: 27.4), a dividend yield of none, and 1-year performance of -4.3%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.

Are insiders buying or selling NEO stock?

There have been 5 insider transactions for NEO in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.

How has NEO stock performed over the past year?

NEOGENOMICS INC (NEO) has returned -4.3% over the past 12 months. The stock traded between $4.72 and $13.74 during this period, and is currently at $8.74.

Which hedge funds own NEO (NEOGENOMICS INC)?

0 tracked hedge funds currently hold NEO in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.

What is NEO's market cap and valuation?

NEOGENOMICS INC (NEO) has a market capitalization of $1.13B. The trailing P/E ratio is N/A and forward P/E is 27.4. The stock is classified in the Healthcare sector.

What is NEO's revenue and profitability?

NEOGENOMICS INC reported revenue of $727.33M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.64.

What sector is NEO in and who are its biggest institutional holders?

NEOGENOMICS INC (NEO) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.